
Article 1 
Implementing Regulation (EU) No 686/2012 is amended in accordance with the Annex to this Regulation.
Article 2 
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
It shall apply from 30 March 2019.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 30 January 2019.
For the Commission
The President
Jean-Claude JUNCKER
ANNEX

The Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:

((1)) Part A is amended as follows:

((a)) the entry for Deltamethrin is replaced by the following:

Active substance Rapporteur Member State Co-rapporteur Member State
‘Deltamethrin AT’ 
((b)) the entry for Diflufenican is replaced by the following:

Active substance Rapporteur Member State Co-rapporteur Member State
‘Diflufenican CZ’ 
((c)) the entry for Fluoxastrobin is replaced by the following:

Active substance Rapporteur Member State Co-rapporteur Member State
‘Fluoxastrobin DE’ 
((d)) the entry for Prothioconazole is replaced by the following:

Active substance Rapporteur Member State Co-rapporteur Member State
‘Prothioconazole PL’ 
((2)) Part B is amended as follows:

((a)) the entry for Epoxiconazole is replaced by the following:

Active substance Rapporteur Member State Co-rapporteur Member State
‘Epoxiconazole PL’ 
((b)) the entry for Tebuconazole is replaced by the following:

Active substance Rapporteur Member State Co-rapporteur Member State
‘Tebuconazole DK’ 
